As of January 1st, 2023, the Vrije Universiteit Amsterdam made Open Access publishing the norm. The new policy means that scientific publications by VU-authors must be made Open Access under an open license.
A study of Marta del Campo, an external collaborator at the department of clinical chemistry at Amsterdam UMC, together with Neurochemistry professor Charlotte Teunissen, reflects the multifactorial nature of Alzheimer’s disease (AD) and identifies specific biomarker panels.
Dagmar Verbaan receives an additional funding from ZonMW to include more patients in the TORCH study, investigating the efficacy of tranexamic acid in patients with a chronic subdural hematoma. TORCH is expected to be completed by the end of 2026.